AQ Biotech

Turku, Finland · Founded 2017 · Privately Held (backing)

Developer of a non-invasive health screening and monitoring system designed for early detection of various diseases, particularly urinary tract cancers, starting from prostate cancers. AQ Biotech is based in Turku, Finland and was founded in 2017. Its last reported valuation was $11.5 million in Apr 2025. It has raised $8.6 million.

Last reported valuation

$11.5M

Oct 2026

Priced at

—

Total raised

$8.6M

Last round

—

How much has AQ Biotech raised?

$8.6Macross 0 recorded rounds

Free account

More of AQ Biotech with a free account

·Watch AQ Biotech: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

AQ Biotech investors

4 investors are on record for AQ Biotech, including Tekes, Corporatum, Keksintösäätiö and Newentures.

For fundraisers

Raising for a company like AQ Biotech?

4 investors have backed AQ Biotech.

See all 4 investors →

Frequently asked about AQ Biotech

How much has AQ Biotech raised?: AQ Biotech has raised $8.6M in total across 0 recorded funding rounds.